fbpx

Insights

We share our knowledge and expertise to update our community and clients about legal developments in Türkiye.

Filters

A New Era in the Pricing of Human Medicinal Products: Euro Exchange Rate Increased to 65% of the Previous Year’s Average, Pricing Incentive Introduced for the First Equivalent/Generic Product

Presidential Decision No. 11031 dated 12 March 2026 (“New Pricing Decision”) has introduced significant changes to the pricing system for human medicinal products that was originally established by Decision No. 2017/9901 and subsequently updated several times. Increasing the adjustment rate used in Euro/TL calculations from 60% to 65%, allowing higher pricing for the first equivalent or generic products to encourage their faster entry into the market, and the inclusion for… »

Children’s Data Security: Current Developments Worldwide and in Türkiye

In the digital ecosystem, children are no longer viewed solely as individuals in need of protection; they have also become one of the central user segments within data-driven business models. Social media platforms, gaming applications, and video-sharing websites systematically process children’s behavioral data, interaction patterns, and content consumption habits. This reality has led to a transformation in the legal approach to children’s data protection, shifting from a… »

Termination of Employment Contract Due to an Employee’s Frequent Medical Reports

The frequent and prolonged medical leave taken by an employee often adversely affects the normal functioning of the workplace and renders the continuation of the employment relationship challenging. Such persistent absenteeism may lead the employer to terminate the employment contract on the grounds of either just cause or a valid reason. Pursuant to Article 18 of the Labor Act No. 4857, the employment contract of an employee benefiting from job security provisions may be… »

New Real-World Data and Pharmacoeconomic Studies for NPP Products

On 19 January 2026, the Turkish Medicines and Medical Devices Agency announced a new initiative focusing on real-world data and pharmacoeconomic analyses for medicines supplied from abroad within the scope of named patient programs. The initiative applies to medicines obtained under the regulation governing the supply of medicines from outside Türkiye, which are typically used in situations where no authorized or available alternative exists in the domestic market and access… »

A New Decision of The Constitutional Court on The Turkish Competition Board’s on-site Inspections

One of the most debated issues in Turkish competition law in 2023 was the decision of the Constitutional Court dated 23 March 2023 (Application No. 2019/40991), in which the Court held that the on-site inspection conducted at the premises of Ford Otomotiv Sanayi A.Ş. violated the constitutional right to the immunity of residence due to its unlawfulness. Following that decision, significant uncertainty arose as to whether the legislature would amend the relevant statutory… »

Court of Cassation Confirms Binding Effect of Agreements Between Parties in Trademark Invalidation Claims

The plaintiff consented to the defendant’s trademark under an agreement but later sought invalidation of the earlier-filed trademark. The Court of Cassation held that the agreement covered the earlier trademark based on the parties’ actual and implied intentions. Filing an invalidation action despite prior consent was found to be contrary to the principle of good faith. In Decision No. 2025/2697 E, 2025/6214 K of 13 October 2025, the Court of Cassation (CoC) upheld the… »

Stay Informed

Subscribe to stay up to date on the latest legal insights and events of your choice.

×

Marking four decades defined by excellence, integrity, and a globally respected presence in the legal profession. Discover our story.